Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
India’s personal care industry is undergoing a fundamental shift in how it thin...
As Aerolase expands in India, what is your strategy for enabling dermatology cl...
India is facing a perilous rise in counterfeit high-value medicines, from cance...
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch...
Your work leverages AI and machine learning to optimise CAR-T cell therapy. How...
From one-size-fits-all to precision medicine: AI’s impact on pharma Drug develo...
The companies are also launching their first collaboratively developed product, ...
Affecting adults and children, this rare, progressive, genetic disorder impacts ...
Indulekha has announced the successful completion of its second large clinical ...
Global pharma major Lupin announced the launch of Atharv Ability, its world-cla...
Dr Amit Kumar: How can policy frameworks better align commercial interests in t...
The offer was approved by Assertio’s Board of Directors, following a revised mer...
The approval covers adults and adolescents in the European Union (EU) who weigh ...
The facility has received EU GMP certification from the Malta Medicines Authori...
This product would be manufactured at Lupin’s Nagpur facility in India The post...
Assertio is focused on specialty and oncology supportive-care therapies The pos...
